Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
---|---|---|---|---|---|---|
Filed 2017-04-12 Tx date 2016-12-22 |
$VBV
VBI Vaccines Inc. |
Lockshin, Curtis
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Subscription Rights Restricted Share Units
58 - Expiration of rights
|
-69,658 vol |
0 | |
Filed 2017-04-12 Tx date 2016-06-22 |
$VBV
VBI Vaccines Inc. |
Lockshin, Curtis
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$54,447
+14,069 vol $3.87 each |
393,125 | |
Filed 2017-04-12 Tx date 2016-12-22 |
$VBV
VBI Vaccines Inc. |
Lockshin, Curtis
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$35,428
+11,037 vol $3.21 each |
404,162 | |
Filed 2017-04-12 Tx date 2015-07-14 |
$VBV
VBI Vaccines Inc. |
Lockshin, Curtis
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Subscription Rights Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2017-04-12 Tx date 2016-06-22 |
$VBV
VBI Vaccines Inc. |
Lockshin, Curtis
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Subscription Rights Restricted Share Units
56 - Grant of rights
|
+112,500 vol |
112,500 | |
Filed 2017-04-12 Tx date 2016-06-22 |
$VBV
VBI Vaccines Inc. |
Lockshin, Curtis
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Subscription Rights Restricted Share Units
57 - Exercise of rights
|
$-108,843.75
-28,125 vol $3.87 each |
84,375 | |
Filed 2017-04-12 Tx date 2016-12-22 |
$VBV
VBI Vaccines Inc. |
Lockshin, Curtis
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Subscription Rights Restricted Share Units
57 - Exercise of rights
|
$-47,241.57
-14,717 vol $3.21 each |
69,658 | |
Filed 2015-07-15 Tx date 2015-07-14 |
$VAC
SciVac Therapeutics Inc. |
Lockshin, Curtis
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
379,056 |